Evaluation of a multiplex panel of immune-related markers in cervical secretions: a methodologic study.
Koshiol, Jill; Sklavos, Martha; Wentzensen, Nicolas; Kemp, Troy; Schiffman, Mark; Dunn, S Terence; Wang, Sophia S; Walker, Joan L; Safaeian, Mahboobeh; Zuna, Rosemary E; Hildesheim, Allan; Pfeiffer, Ruth M; Pinto, Ligia A.
Int J Cancer
; 134(2): 411-25, 2014 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-23824624
Cytology versus HPV testing for cervical cancer screening in the general population.
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Follow-up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) test.
Prevalence of human papillomavirus in the saliva of sexually active women with cervical intraepithelial neoplasias.
The Role of the Cervicovaginal Microbiome on the Genesis and as a Biomarker of Premalignant Cervical Intraepithelial Neoplasia and Invasive Cervical Cancer.
Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCM.
Disease detection at the 48-month exit round of the HPV FOCAL cervical cancer screening trial in women per-protocol eligible for routine screening.
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
Genome-wide microRNA analysis of HPV-positive self-samples yields novel triage markers for early detection of cervical cancer.
Retinoids for preventing the progression of cervical intra-epithelial neoplasia.